chr11-65856059-T-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The NM_005507.3(CFL1):c.187A>T(p.Thr63Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000533 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005507.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005507.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CFL1 | TSL:1 MANE Select | c.187A>T | p.Thr63Ser | missense | Exon 2 of 4 | ENSP00000309629.5 | P23528 | ||
| CFL1 | TSL:1 | c.136A>T | p.Thr46Ser | missense | Exon 1 of 3 | ENSP00000436899.1 | E9PQB7 | ||
| CFL1 | TSL:2 | c.301A>T | p.Thr101Ser | missense | Exon 2 of 4 | ENSP00000431696.1 | E9PK25 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251490 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461886Hom.: 0 Cov.: 34 AF XY: 0.0000481 AC XY: 35AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.